Chemical structure-guided design of dynapyrazoles, cell-permeable dynein inhibitors with a unique mode of action.

TitleChemical structure-guided design of dynapyrazoles, cell-permeable dynein inhibitors with a unique mode of action.
Publication TypeJournal Article
Year of Publication2017
AuthorsSteinman JB, Santarossa CC, Miller RM, Yu LS, Serpinskaya AS, Furukawa H, Morimoto S, Tanaka Y, Nishitani M, Asano M, Zalyte R, Ondrus AE, Johnson AG, Ye F, Nachury MV, Fukase Y, Aso K, Foley MA, Gelfand VI, Chen JK, Carter AP, Kapoor TM
JournalElife
Volume6
Date Published2017 05 19
ISSN2050-084X
KeywordsCrystallography, X-Ray, Dyneins, Enzyme Inhibitors, Humans, Molecular Structure, Pyrazoles, Quinazolinones
Abstract

Cytoplasmic dyneins are motor proteins in the AAA+ superfamily that transport cellular cargos toward microtubule minus-ends. Recently, ciliobrevins were reported as selective cell-permeable inhibitors of cytoplasmic dyneins. As is often true for first-in-class inhibitors, the use of ciliobrevins has in part been limited by low potency. Moreover, suboptimal chemical properties, such as the potential to isomerize, have hindered efforts to improve ciliobrevins. Here, we characterized the structure of ciliobrevins and designed conformationally constrained isosteres. These studies identified dynapyrazoles, inhibitors more potent than ciliobrevins. At single-digit micromolar concentrations dynapyrazoles block intraflagellar transport in the cilium and lysosome motility in the cytoplasm, processes that depend on cytoplasmic dyneins. Further, we find that while ciliobrevins inhibit both dynein's microtubule-stimulated and basal ATPase activity, dynapyrazoles strongly block only microtubule-stimulated activity. Together, our studies suggest that chemical-structure-based analyses can lead to inhibitors with improved properties and distinct modes of inhibition.

DOI10.7554/eLife.25174
Alternate JournalElife
PubMed ID28524820
PubMed Central IDPMC5478271
Grant ListR21 HD087126 / HD / NICHD NIH HHS / United States
R01 GM052111 / GM / NIGMS NIH HHS / United States
MC_UP_A025_1011 / / Medical Research Council / United Kingdom
R01 GM098579 / GM / NIGMS NIH HHS / United States
R01 GM113100 / GM / NIGMS NIH HHS / United States
/ / Wellcome Trust / United Kingdom
S10 OD016320 / OD / NIH HHS / United States
T32 GM007739 / GM / NIGMS NIH HHS / United States
R01 GM089933 / GM / NIGMS NIH HHS / United States

Person Type: